RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Star Combo Pharma Stock

Star Combo Pharma Stocks 2025

Star Combo Pharma Stocks

135.08 M

Ticker

S66.AX

ISIN

AU0000004798

In 2025, Star Combo Pharma had 135.08 M outstanding stocks, a 0% change from the 135.08 M stocks in the previous year.

The Star Combo Pharma Stocks history

YEARNUMBER OF STOCKS (undefined AUD)
2024135.08
2023135.08
2022134.58
2021134.79
202091.42
201982.14
201862.66
201775.51
201675.51
201575.51
201475.51

Star Combo Pharma shares outstanding

The number of shares was Star Combo Pharma in 2024 — This indicates how many shares 135.083 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Star Combo Pharma earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Star Combo Pharma's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Star Combo Pharma’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Star Combo Pharma's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Star Combo Pharma Aktienanalyse

What does Star Combo Pharma do?

Star Combo Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Star Combo Pharma's Shares Outstanding

Star Combo Pharma's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Star Combo Pharma’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Star Combo Pharma’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Star Combo Pharma’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Star Combo Pharma stock

How many stocks are there of Star Combo Pharma?

The current number of stocks of Star Combo Pharma is 135.08 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Star Combo Pharma are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Star Combo Pharma evolved in recent years?

The number of shares of Star Combo Pharma has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Star Combo Pharma as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Star Combo Pharma?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Star Combo Pharma pay?

Over the past 12 months, Star Combo Pharma paid a dividend of 0 AUD . This corresponds to a dividend yield of about 3.79 %. For the coming 12 months, Star Combo Pharma is expected to pay a dividend of 0 AUD.

What is the dividend yield of Star Combo Pharma?

The current dividend yield of Star Combo Pharma is 3.79 %.

When does Star Combo Pharma pay dividends?

Star Combo Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Star Combo Pharma?

Star Combo Pharma paid dividends every year for the past 1 years.

What is the dividend of Star Combo Pharma?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 3.79 %.

In which sector is Star Combo Pharma located?

Star Combo Pharma is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Star Combo Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Star Combo Pharma from 10/31/2024 amounting to 0.005 AUD, you needed to have the stock in your portfolio before the ex-date on 10/14/2024.

When did Star Combo Pharma pay the last dividend?

The last dividend was paid out on 10/31/2024.

What was the dividend of Star Combo Pharma in the year 2024?

In the year 2024, Star Combo Pharma distributed 0 AUD as dividends.

In which currency does Star Combo Pharma pay out the dividend?

The dividends of Star Combo Pharma are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Star Combo Pharma

Our stock analysis for Star Combo Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Star Combo Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.